Investors sold shares of several third-party logistics companies Friday after a large nuclear verdict in a Texas court against C.H. Robinson raised questions about potential liability across the freight brokerage industry. In transportation litigation, “nuclear verdict” is commonly used to describe an exceptionally large jury award, often large enough to affect insurance, legal strategy and investor expectations.

C.H. Robinson (NASDAQ: CHRW) dropped $19, or 9.25%, to $186.50. Two days earlier, the stock had reached a 52-week high of $210.33.

RXO (NYSE: RXO) also declined after the decision, falling 7.71%, or $2.14, to $25.63. RXO had reached its own 52-week high Tuesday at $29.90.

Landstar (NYSE: LSTR) fell $7.65, or 3.68%, to $200.32. Its 52-week high was $228.46 on June 8.

The S&P 500 was marginally higher for the day.

Analysts point to a possible first domino

TD Cowen’s research team summarized the view of investors selling 3PL shares after the decision in Lipe vs. Lupus Superior in a brief report titled “The First Domino to Fall?”

“C.H. Robinson faces the first post-Montgomery ruling nuclear verdict,” the report said. “We view this as a negative for brokers.”

In the Dallas County court case, a group of plaintiffs sued several companies and individuals tied to a 2021 crash that killed three people and the employee driver of carrier Lupus Superior. C.H. Robinson had hired Lupus Superior to move a load of beverages from Arizona Beverages.

That broker-carrier relationship is central to the industry concern. Freight brokers arrange transportation between shippers and motor carriers, but they generally do not operate the trucks or directly employ the carrier’s drivers. The verdict therefore drew attention not only because of its size, but because of how liability may be assigned when a broker selects a federally authorized carrier.

On Thursday, the jury awarded approximately $604 million in compensatory damages. The award is structured in a way that most likely places the payment burden on C.H. Robinson. The company has said it plans to appeal.

A defense previously used in such cases — that 3PLs are protected under the safety exception of the Federal Aviation Administration Authorization Act, or F4A — was eliminated in May by the Supreme Court’s unanimous ruling in Montgomery vs. Caribe Transport II, which rejected that interpretation of the law. C.H. Robinson had been an original defendant in that case, but both a district court and an appellate court had invoked F4A to remove the company from the litigation.

Bank of America says the process will not be quick

Ken Hoexter of Bank of America wrote in commentary on the case that the Lipe vs. Lupus decision marks only the beginning of the next phase.

Under a headline stating that the “process will be long,” the Bank of America report cited C.H. Robinson’s statements and said “the verdict is one step in a process, does not determine what CHRW will pay, with any final outcome subject to post-trial motions, appeals, and other proceedings.”

Judge Dianne Jones has not yet certified the jury award.

Several Wall Street analyst reports focused on the fact that Lupus Superior had a Satisfactory safety rating from the Federal Motor Carrier Safety Administration before the crash, and that the rating was affirmed afterward.

TD Cowen said that fact “(suggests) that CHRW was working with a high-quality carrier (at least in the eyes of FMCSA’s standards).”

Satisfactory rating may not shield brokers

TD Cowen analysts wrote that the jury decision “puts the company and broker in a difficult position. If a carrier with a satisfactory FMCSA rating is insufficient, what standard should brokers use when determining which carriers are permitted on their platforms?”

That question had been raised by the brokerage industry before the Supreme Court case. In an amicus brief filed before the decision, Marc Blubaugh of the Benesch law firm, representing the Transportation Intermediaries Association, warned of potential problems if a broker’s decision were treated as overriding a federal judgment about a carrier’s safety practices.

“No valid way exists for a broker to compare and contrast motor carrier safety records in any consistent and meaningful way in order to yield uniform outcomes necessary for efficient interstate commerce,” Blubaugh wrote. “Even given identical facts, judges and juries across the nation’s myriad state and federal jurisdictions would inevitably reach contrary and conflicting conclusions as to the adequacy of a broker’s choice of federally authorized motor carrier.”

Potential earnings impact remains uncertain

TD Cowen said it did not expect C.H. Robinson to record a charge against earnings “immediately…as the case remains subject to appeal.” However, the firm said such a charge could occur later.

If C.H. Robinson does take a charge, it would resemble trailer manufacturer Wabash National (NYSE: WNC) taking a $342 million charge in 2025 related to its own nuclear verdict. When that case was eventually settled, Wabash reduced the size of the charge.

TD Cowen’s report described a difficult outlook for the sector.

“Verdicts are coming faster than most expected,” the analysts wrote. “Many pending court cases were waiting for the SCOTUS ruling for more clarity and are now moving forward in the courts. This is…a new reality many brokers will now live with and investors need to assess the risks of more nuclear verdicts in the future.”

Beyond the size of the award, another jury finding drew industry attention: the decision that the Lupus Superior driver was also effectively an employee of C.H. Robinson, even though C.H. Robinson does not directly hire drivers.

“This treatment is what makes the deceased driver’s liability become Robinson’s,” Stephens analyst Bascome Majors wrote in a report.

Majors wrote that C.H. Robinson does not appear likely to move quickly toward a settlement, but added that “even a settlement for $150 to $350 million is clearly bad news for C.H. Robinson.”

Majors and TD Cowen both noted in their reports that C.H. Robinson’s liability structure includes a $10 million deductible and a $135 million limit.

“If the company sees favorable developments in the appeals process, estimable losses could fall within C.H. Robinson’s coverage tower, capping losses to the self-insured limit, which would minimize the hit to profits and losses,” TD Cowen said.

The litigation path for freight brokers after the Montgomery decision may take years to unfold. The Dallas case, Lipe vs. Lupus, is the first major case in that longer process.